A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Advanced Solid TumorSolid Tumor
Interventions
DRUG

BGB-26808

Planned doses administered orally as a tablet daily.

DRUG

Tislelizumab

Planned doses administered by intravenous infusion.

DRUG

Chemotherapy

Administered in accordance with relevant local guidelines and/or prescribing information.

Trial Locations (28)

1023

RECRUITING

Auckland City Hospital, Auckland

RECRUITING

Harbour Cancer and Wellness, Auckland

3010

NOT_YET_RECRUITING

Health New Zealand Te Whatu Ora Lakes Rotorua Hospital, Rotorua

33136

RECRUITING

Sylvester Cancer Center, University of Miami, Miami

90033

NOT_YET_RECRUITING

University of Southern Californianorris Comprehensive, Los Angeles

110167

RECRUITING

The First Hospital of China Medical University Hunnan Branch, Shenyang

150000

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

200123

RECRUITING

Shanghai East Hospital Branch Hospital, Shanghai

200433

COMPLETED

Shanghai Pulmonary Hospital, Shanghai

230022

RECRUITING

The First Affiliated Hospital of Anhui Medical Universitygaoxin Branch, Hefei

264000

RECRUITING

Yantai Yuhuangding Hospital, Yantai

272000

RECRUITING

Jining No Peoples Hospital West Branch, Jining

310006

RECRUITING

Hangzhou First Peoples Hospital, Hangzhou

317004

COMPLETED

Taizhou Hospital of Zhejiang Province (East), Taizhou

430079

RECRUITING

Hubei Cancer Hospital, Wuhan

430101

RECRUITING

Tongji Hospital,Tongji Medical College of Hustsino French New City Branch, Wuhan

610071

RECRUITING

Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu

91010-3012

NOT_YET_RECRUITING

City of Hope National Medical Center, Duarte

06520-8028

RECRUITING

Yale University, Yale Cancer Center, New Haven

48109-1382

NOT_YET_RECRUITING

University of Michigan, Ann Arbor

07601-2191

RECRUITING

John Theurer Cancer Center Hackensack University Medical Center, Hackensack

10029-6504

RECRUITING

Icahn School of Medicine At Mount Sinai, New York

97213-2933

RECRUITING

Providence Portland Medical Center, Portland

77030-4009

RECRUITING

The University of Texas Md Anderson Cancer Center, Houston

NSW 2228

COMPLETED

Southside Cancer Care, Miranda

NSW 2109

RECRUITING

Macquarie University, North Ryde

SA 5037

RECRUITING

Icon Cancer Centre Kurralta Park, Kurralta Park

WA 6009

RECRUITING

Linear Clinical Research, Nedlands

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeiGene

INDUSTRY